[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 2252 Introduced in Senate (IS)]

<DOC>






116th CONGRESS
  1st Session
                                S. 2252

 To amend title XIX of the Social Security Act to expand the permitted 
 uses of drug price information disclosed to States under the Medicaid 
                          drug rebate program.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 24, 2019

 Mr. Van Hollen (for himself and Mr. Cardin) introduced the following 
  bill; which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL


 
 To amend title XIX of the Social Security Act to expand the permitted 
 uses of drug price information disclosed to States under the Medicaid 
                          drug rebate program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Empowering States to Address Drug 
Costs Act''.

SEC. 2. EXPANSION OF PERMITTED USES OF DRUG PRICE INFORMATION DISCLOSED 
              TO STATES UNDER MEDICAID DRUG REBATE PROGRAM.

    Clause (iv) of section 1927(b)(3)(D) of the Social Security Act (42 
U.S.C. 1396r-8(b)(3)(D)) is amended to read as follows:
                            ``(iv) to States--
                                    ``(I) to carry out this title, or
                                    ``(II) to review the information 
                                provided (including average 
                                manufacturer price, best price, and 
                                rebate calculation data) for the 
                                purposes of establishing and operating 
                                State all-payer prescription drug rate 
                                setting entities (drug affordability 
                                boards) or State multi-payer purchasing 
                                pools,''.
                                 <all>